Mutual Funds Commodities Research Tax Planning IPO Our Team Contact Us  

| More

BFSI - New normal rate cycle; brace for transmission effects - HDFC Securities

Posted On: 2022-06-11 13:20:22 (Time Zone: IST)

Krishnan ASV, Institutional Research Analyst, HDFC Securities and Deepak Shinde, Institutional Research Analyst, HDFC Securities.

Signalling its serious intent to rein in a galloping inflation, the RBI announced a 50bps repo rate hike in its monetary policy meeting, close on the heels of its out-of-turn 40bps rate hike last month. Although the financial services sector has witnessed multiple interest rate cycles in the past, we argue that this rate hike cycle is different on account of a) accelerated nature of policy rate hikes (90bps within a span of 30 days); and b) loan pricing regime (mix of loan book linked to external benchmark with shorter resets). Unlike in the past, banks are likely to witness margin accretion during this stage of the up-cycle, given a near[1]complete pass-through on the asset side of the balance sheet thus far. However, the margin-pop is likely to be short-lived (next couple of quarters) with the pace of asset-side transmission gradually diminishing and lagged re-pricing of deposits. We identify ICICIBC (67% of loan book) and SBIN (75% of loan book) as best placed to capitalise on this stage of the rate cycle.

Accelerated rate hike; more in the offing: In its response to a stubborn and elevated inflation print, the RBI has now effected an accelerated cumulative 90bps repo rate hike over the past few weeks. Concomitant with a 50bps CRR hike and the withdrawal of a hitherto-accommodative policy stance, we expect the pace of policy rate normalisation to continue.

Near-total pass-through a surprise; near-term margin-accretive: Unlike earlier up-cycles in the past, the sharp pace of rate normalisation is margin[1]accretive for banks in the near-term, especially given early-stage monetary transmission. Nudged by the RBI, banks have gradually migrated their lending portfolios towards EBLR-linked loans (externally benchmarked lending rates) with ~40% of loans across retail segments anchored to the repo rate. Leading private banks have 35-50% of their loan book currently linked to EBLR, with a 3-month reset clause.

MCLR transmission to significantly lag EBLR transmission: At a system[1]wide level, ~20-30% of the aggregate loans are currently anchored to MCLR while 40% of the loans are anchored to EBLR. Given the sheer pace of rate normalisation, we expect transmission on the MCLR book to significantly lag transmission on the EBLR portfolio, both in terms of the quantum (extent of pass-through) and timing (EBLR will be more immediate).

MSME and housing portfolios likely to reflate fastest: Given the mix of pricing regime across asset classes and the likely sequence of transmission, we expect asset yields in MSME (70% EBLR linked) and housing portfolios (60% EBLR linked) to reflate the fastest and more quickly compared to the rest of the portfolios. However, given these are crowded segments, the pass[1]through is likely to incrementally diminish through the up-cycle on account of the competitive intensity in these categories.

Lagged deposit-side re-pricing: The re-pricing of the deposit side of the balance sheet is likely to happen gradually, given the surplus liquidity in the system and healthy C/D ratios. Banks have raised their term deposit pricing by ~10-25bps over the past few months, which is likely to gradually reflect in the incremental cost of funds for the banking system.

ICICIBC and SBIN best levered to up-cycle: We identify ICICIBC (48% EBLR; 22% MCLR for the domestic loan book) and SBIN (34% EBLR; 41% MCLR) as best positioned to capitalise on this stage of the rate cycle.

Click here to send ur comments or to

Disclaimer:The article above is a gist / extract of the original report prepared by the research firm / brokerage firm. This article is not to be considered as an offer to sell or a solicitation to buy any securities. This article is meant for general information only., its employees or owners or the research firms, its employees or owners won't be responsible for any liability that may arise from information, errors or omissions in these articles. or its employees or owners / the research firms or its employees or clients or owners may from time to time hold positions in securities referred in this article. For detailed research reports, please contact the concerned research firm directly.

Other Headlines:

Gladiator Stocks - Minda Industries - ICICI Direct

Reliance Industries - Company Update - In fine fettle amidst global uncertainty - BUY

Sector Update - Sugar - ICICI Direct

Initiating Coverage - Hindustan Aeronautics Ltd - ICICI Direct

Rallis India - Company Update - Margin pressure likely to persist in near term..!! - Upgrade to 'BUY'

Indoco Remedies - Q4FY22 Result Update - In-line quarter; strong revenue guidance for US & EU mkt - Upgrade to 'BUY'

Indraprastha Gas - Q4FY22 Result Update - Impressive performance - BUY

KEC International - Annual Report Analysis - Healthy outlook across business segment - Accumulate

Westlife Development - Q4FY22 Result Update - Approaching the tipping point; Buy for LT Gains

Reliance Research downgrades Bajaj Auto to Sell

NOCIL - Q4FY22 Result Update - Strong operating performance amidst challenges - BUY

Gujarat Gas - Company Update - Deftly negotiating through tough times - BUY

Orient Electric - Gaining market share via innovation: initiate with ADD - ICICI Securities

Manappuram Finance - Q4FY22 Result Update - Intense Competition Put Pressure on Yields - BUY

Derivatives Weekly View - June 24, 2022 - ICICI Direct

Stock Tales - Newgen Software - ICICI Direct

Weekly Report - June 25, 2022 - Mr. Mitul Shah - Head of Research at Reliance securities

Gladiator Stocks - Bosch - ICICI Direct

Management Meet Update - Sheela Foam - ICICI Direct

Gladiator Stocks - Mahindra & Mahindra - ICICI Direct

Banks - Modifications to PPI and its impact on cards - Negligible impact, if any, for stocks under coverage

LIC Housing Finance - Q4FY22 Result Update - Fixed rate liabilities could cushion NIM - BUY

Navneet Education - Q4FY22 Result Update - Growth levers in place - BUY

MPC Minutes: Jun-22: All eyes on inflation - Acuité Ratings

Nazara Technologies - Management Meet Update - Breaking through the ESports landscape - BUY

Sector update - Quick Service Restaurants - YES Securities

JK Lakshmi Cement - Q4FY22 Result Update - Strong performance; Valuations drive upgrade - Accumulate

Would it be wise to invest in a home early in your career?

Dr. Reddy's Laboratories - Analyst Meet Update - Multiple growth initiatives - BUY

Dhanuka Agritech - Management Meet Update - 1Q likely to be subdued; all hopes pinned on the monsoons - BUY

BUY Ipca Laboratories - Q4FY22 Result Update - Weak exports; gradual recovery

Acuité expects India's current account deficit to widen to more than USD 90 bn in FY23 - Acuité Macro Pulse

Inflationary concerns will continue to weigh on the pace of economic revival in FY23 - Acuité Macroeconomic Performance index

City Union Bank - Q4FY22 Result Update - Asset quality on the mend - BUY

Banks - BNPL - Early results are not that exciting as yet - Kotak

Acuité expects FY23 GDP growth estimate at 7.5% - Acuité Macro Pulse - Growth - May-22 Edition

Base factor pushes up IIP in Apr-22 to an 8-month high - Acuité Ratings

India Strategy & Q4FY22 Review - Long term growth prospects to overshadow near term uncertainties

India Equity Strategy - Quarterly flipbook: Q4FY22-Cost inflation driving downgrades

FMCG - D2C is here to stay; omni-channel the way forward - HDFC Securities

Automobile Sector - Monthly Quick View - May'22 - Steady Performance Improvement, backed by Gradual Rural Recovery

SBI Cards and Payment Services - BUY - TP Rs. 1260 - YES SECURITIES

RBI frontloads rate hike amid increased inflationary headwinds - Acuité Ratings

Monetary Policy June 2022 - Axis MF Views

RBI Monetary Policy View - Mr. Dhiraj Relli, MD & CEO, HDFC Securities

Monetary Policy - entering the red zone - Anuj Puri, ANAROCK

Mr. Murali Ramakrishnan, MD &CEO, South Indian Bank on RBI Monetary Policy

Comments on RBI's MPC Policy Jun'22 - Acuité Ratings

Views on RBI Monetary Policy - June 2022

Bayer Cropscience - Q4FY22 Result Update - Healthy all round performance - BUY

Website Created & Maintained by : Chennai Scripts
West Mambalam, Chennai - 600 033,
Tamil Nadu, India

disclaimer copyright © 2005 - 2020